SCHEMBL4674577

SCHEMBL4674577

CC(=O)c1ccc(Cc2c[nH]c(C(=O)C=C(O)C(=O)O)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.49
LMNA P02545 1/20 0.48
SMYD3 Q9H7B4 1/20 0.36
HSD17B10 Q99714 1/20 0.35
DAO P14920 1/20 0.35
TBXAS1 P24557 2/20 0.34
PYCR1 P32322 1/20 0.33
TSHR P16473 1/20 0.33
AKR1C3 P42330 1/20 0.33
SRD5A2 P31213 1/20 0.33
PLA2G10 O15496 1/20 0.32
PLA2G2A P14555 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAOB P27338 1/20 0.31
MAPT P10636 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4674575 1.00 KMT2A (0.49) KMT2ALMNASMYD3HSD17B10DAO
SCHEMBL4675216 0.87 SRD5A2 (0.40) KMT2ALMNADAOAKR1C3SRD5A2
SCHEMBL4675213 0.87 SRD5A2 (0.40) KMT2ALMNADAOAKR1C3SRD5A2
SCHEMBL4675566 0.85 GAA (0.39) KMT2ALMNADAOPLA2G10PLA2G2A
SCHEMBL4675568 0.85 GAA (0.39) KMT2ALMNADAOPLA2G10PLA2G2A
SCHEMBL4675878 0.84 DAO (0.37) KMT2ALMNADAOALDH1A1L3MBTL1
SCHEMBL4675875 0.84 DAO (0.37) KMT2ALMNADAOALDH1A1L3MBTL1
SCHEMBL4670509 0.84 ALDH1A1 (0.38) DAOTSHRPLA2G10PLA2G2AALDH1A1
SCHEMBL4670512 0.84 ALDH1A1 (0.38) DAOTSHRPLA2G10PLA2G2AALDH1A1
SCHEMBL4676087 0.84 LTA4H (0.42) DAOAKR1C3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
CN-1335834-A Aromatic heterocyclic compounds having HIV integrase inhibitory activity SHIONOGI & CO (JP) 2002-02-13 CN disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 KMT2A 597/4885LMNA 659/4885SMYD3 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.